 <h1>Versed Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>midazolam</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about midazolam. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Versed.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to midazolam: injection solution</i></p><p>Other dosage forms:</p><ul><li>nasal spray</li><li>oral syrup</li></ul><h3>Warning</h3><p class="blackboxWarning-title">Injection route (Solution)</p><p>Midazolam has been associated with respiratory depression and respiratory arrest, especially when used for sedation in noncritical care settings. Use only in settings that can provide for continuous monitoring of respiratory and cardiac function. The initial dose and all subsequent doses should always be titrated slowly. Midazolam injection should not be administered by rapid injection in the neonatal population as severe hypotension and seizures have been reported.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, midazolam (the active ingredient contained in Versed) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking midazolam:</p><p>
<i>Less common</i>
</p><ul>
<li>Aggressiveness</li>
<li>agitation</li>
<li>anxiety</li>
<li>choking</li>
<li>confusion</li>
<li>decreased awareness or responsiveness</li>
<li>decreased urine output</li>
<li>difficulty walking, speaking, or writing</li>
<li>discouragement</li>
<li>dizziness</li>
<li>feeling sad or empty</li>
<li>fever</li>
<li>headache</li>
<li>irritability</li>
<li>lack of appetite</li>
<li>loss of bladder or bowel control</li>
<li>loss of consciousness</li>
<li>loss of interest or pleasure</li>
<li>memory loss</li>
<li>muscle twitching</li>
<li>nausea</li>
<li>nightmares or unusually vivid dreams</li>
<li>rapid weight gain</li>
<li>seizures</li>
<li>severe sleepiness</li>
<li>strong urge to urinate</li>
<li>swelling of the face, ankles, or hands</li>
<li>thirst</li>
<li>trouble concentrating</li>
<li>trouble sleeping</li>
<li>troubled breathing</li>
<li>unable to speak</li>
<li>unusual drowsiness, dullness, tiredness, weakness, or feeling of sluggishness</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of midazolam may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Bleeding, blistering, burning, coldness, discoloration of skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Muscle stiffness</li>
</ul><p>
<div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to midazolam: compounding powder, injectable solution, intravenous solution, nasal spray, oral syrup</i></p><h3>General</h3><p>The most commonly reported side effects with oral formulations include emesis and nausea.  Decreased tidal volume/respiratory rate and apnea were most commonly reported with parenteral formulations.<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Oral:</p>
<p><b>Very common</b> (10% or more): Respiratory adverse events (up to 11%)</p>
<p><b>Common</b> (1% to 10%): Respiratory depression, hypoxia, laryngospasm, upper airway obstruction, rhonchi, congestion</p>
<p><b>Uncommon</b> (0.1% to 1%): Sneezing/rhinorrhea</p>
<p><b>Frequency not reported</b>: Apnea, hypercarbia, desaturation, stridor, hiccough</p>
<p></p>
<p>Parenteral:</p>
<p><b>Very common</b> (10% or more): Decreased tidal volume/respiratory rate (up to 23.3%), apnea (up to 15.4%)</p>
<p><b>Common</b> (1% to 10%): Hiccoughs, coughing, desaturation</p>
<p><b>Very rare</b> (less than 0.01%): Dyspnea, hiccup, laryngospasm, respiratory arrest</p>
<p><b>Frequency not reported</b>: Respiratory depression</p>
<p><b>Postmarketing reports</b>: Bronchospasm, hyperventilation, wheezing, shallow respirations, airway obstruction, tachypnea, dysphonia, yawning, continued phonation<sup>[Ref]</sup></p><p>Respiratory adverse events included hypoxia, laryngospasm, rhonchi, coughing, respiratory depression, airway obstruction, upper airway congestion, and shallow respirations; these side effects occurred more frequently at higher doses.</p>
<p></p>
<p>Decreased tidal volume/respiratory rate occurred in 23.3% of patients given IV formulations and in 10.8% of patients given IM formulations.</p>
<p></p>
<p>Apnea occurred in 15.4% of patients given IV formulations.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Oral:</p>
<p><b>Very common</b> (10% or more): Emesis/vomiting (up to 11%)</p>
<p><b>Common</b> (1% to 10%): Nausea</p>
<p><b>Frequency not reported</b>: Gagging, salivation</p>
<p></p>
<p>Parenteral:</p>
<p><b>Common</b> (1% to 10%): Nausea, vomiting</p>
<p><b>Very rare</b> (less than 0.01%): Constipation, dry mouth</p>
<p><b>Postmarketing reports</b>: Acid taste, excessive salivation, retching, toothache<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Oral:</p>
<p><b>Common</b> (1% to 10%): Sedation/prolonged sedation, somnolence, depressed levels of consciousness</p>
<p><b>Frequency not reported</b>: Drooling, dizziness, ataxia, vertigo, dysarthria, loss of balance</p>
<p></p>
<p>Parenteral:</p>
<p><b>Common</b> (1% to 10%): Headache, oversedation, drowsiness, seizure-like activity</p>
<p><b>Very rare</b> (less than 0.01%): Movement disorder, ataxia, dizziness, seizure, anterograde amnesia</p>
<p><b>Frequency not reported</b>: Involuntary movements, hyperactivity, decreased alertness, somnolence, prolonged/postoperative sedation, convulsions/drug withdrawal convulsions, feeling faint, tonic/clonic movements and muscle tremor</p>
<p><b>Postmarketing reports</b>: Vasovagal episode, retrograde amnesia, grogginess, athetoid movements, lethargy, slurred speech, paresthesia, loss of balance, lightheadedness, feeling of burning, emergence delirium or agitation<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>Oral:</p>
<p><b>Common</b> (1% to 10%): Bradycardia, bigeminy</p>
<p><b>Frequency not reported</b>: Increased heart rate, cardiac arrest, heart failure, decreased systolic and diastolic blood pressure</p>
<p></p>
<p>Parenteral:</p>
<p><b>Common</b> (1% to 10%): Hypotension</p>
<p><b>Very rare</b> (less than 0.01%): Bradycardia, cardiac arrest, vasodilation</p>
<p><b>Frequency not reported</b>: Thrombophlebitis, thrombosis, variations in blood pressure and pulse rate</p>
<p><b>Postmarketing reports</b>: Bigeminy, premature ventricular contractions, tachycardia, nodal rhythm, hematoma, cardiovascular collapse, cardiovascular reactions, severe cardiorespiratory adverse events<sup>[Ref]</sup></p><h3>Local</h3><p>Parenteral:</p>
<p><b>Common</b> (1% to 10%): IM injection site pain, IV site tenderness/pain during injection/redness/induration</p>
<p><b>Uncommon</b> (0.1% to 1%): IM injection site induration/redness/muscle stiffness, IV site phlebitis</p>
<p><b>Frequency not reported</b>: Injection site erythema, injection site pain</p>
<p><b>Postmarketing reports</b>: Hive-like elevation at injection site, warmth or coldness at injection site<sup>[Ref]</sup></p><h3>Psychiatric</h3><p>Oral:</p>
<p><b>Common</b> (1% to 10%): Agitation</p>
<p><b>Frequency not reported</b>: Dysphoria, disinhibition, excitation, aggression, mood swings, hallucinations, confusion, inappropriate/adverse behavior, behavioral/emotional disorders, euphonia, libido disorders, restlessness, irritability, delusions, anger eruptions, nightmares, psychosis, physical dependency, withdrawal symptoms, abuse, depression (existing, unobserved depression) </p>
<p></p>
<p>Parenteral:</p>
<p><b>Very rare</b> (less than 0.01%): Aggression/aggressiveness, agitation, anger, hallucination, hostility, confusion/confusional state, euphoric mood/euphoria</p>
<p><b>Frequency not reported</b>: Rage, excitement/paroxysmal excitement, abuse, physical drug dependence and withdrawal syndrome</p>
<p><b>Postmarketing reports</b>: Argumentativeness, nervousness, anxiety, restlessness, sleep disturbance, insomnia, nightmares, dysphoria, irritability, tension, mood changes, dreaming during sleep<sup>[Ref]</sup></p><h3>Dermatologic</h3><p>Oral:</p>
<p><b>Common</b> (1% to 10%): Rash</p>
<p><b>Uncommon</b> (0.1% to 1%): Pruritus and urticaria</p>
<p></p>
<p>Parenteral:</p>
<p><b>Frequency not reported</b>: Angioedema</p>
<p><b>Postmarketing reports</b>: Hives, rash, pruritus, skin reactions<sup>[Ref]</sup></p><h3>Ocular</h3><p>Oral:</p>
<p><b>Frequency not reported</b>: Diplopia, strabismus, blurred vision</p>
<p></p>
<p>Parenteral:</p>
<p><b>Common</b> (1% to 10%): Nystagmus</p>
<p><b>Postmarketing reports</b>: Blurred vision, diplopia, pinpoint pupils, visual disturbance, difficulty focusing eyes, cyclic movement of the eyelids<sup>[Ref]</sup></p><h3>Other</h3><p>Oral:</p>
<p><b>Frequency not reported</b>: Fatigue, falls</p>
<p></p>
<p>Parenteral:</p>
<p><b>Common</b> (1% to 10%): Paradoxical reaction</p>
<p><b>Very rare</b> (less than 0.01%): Fatigue, falls, assault/physical assault</p>
<p><b>Postmarketing reports</b>: Prolonged emergence from anesthesia, blocked ears, chills, weakness, swelling, dreaming during emergence<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>Oral:</p>
<p><b>Frequency not reported</b>: Hypersensitivity</p>
<p></p>
<p>Parenteral:</p>
<p><b>Frequency not reported</b>: Hypersensitivity, anaphylactic shock</p>
<p><b>Postmarketing reports</b>: Allergic reaction, anaphylactoid reactions<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>Oral:</p>
<p><b>Frequency not reported</b>: Muscle weakness, fractures</p>
<p></p>
<p>Parenteral:</p>
<p><b>Frequency not reported</b>: Fractures<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. "Product Information. Versed (midazolam)." Roche Laboratories, Nutley, NJ. </p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Versed (midazolam)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>54 Reviews</li>
<li>Drug class: benzodiazepines</li>
<li>FDA Alerts (5)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Versed injection</li>
<li>Versed &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
<li>Versed Injection &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Nayzilam</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>ICU Agitation</li>
<li>Light Sedation</li>
<li>Light Anesthesia</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to midazolam: compounding powder, injectable solution, intravenous solution, nasal spray, oral syrup</i></p><h3>General</h3><p>The most commonly reported side effects with oral formulations include emesis and nausea.  Decreased tidal volume/respiratory rate and apnea were most commonly reported with parenteral formulations.<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Oral:</p><p><b>Very common</b> (10% or more): Respiratory adverse events (up to 11%)</p><p><b>Common</b> (1% to 10%): Respiratory depression, hypoxia, laryngospasm, upper airway obstruction, rhonchi, congestion</p><p><b>Uncommon</b> (0.1% to 1%): Sneezing/rhinorrhea</p><p><b>Frequency not reported</b>: Apnea, hypercarbia, desaturation, stridor, hiccough</p><p></p><p>Parenteral:</p><p><b>Very common</b> (10% or more): Decreased tidal volume/respiratory rate (up to 23.3%), apnea (up to 15.4%)</p><p><b>Common</b> (1% to 10%): Hiccoughs, coughing, desaturation</p><p><b>Very rare</b> (less than 0.01%): Dyspnea, hiccup, laryngospasm, respiratory arrest</p><p><b>Frequency not reported</b>: Respiratory depression</p><p><b>Postmarketing reports</b>: Bronchospasm, hyperventilation, wheezing, shallow respirations, airway obstruction, tachypnea, dysphonia, yawning, continued phonation<sup>[Ref]</sup></p><p>Respiratory adverse events included hypoxia, laryngospasm, rhonchi, coughing, respiratory depression, airway obstruction, upper airway congestion, and shallow respirations; these side effects occurred more frequently at higher doses.</p><p></p><p>Decreased tidal volume/respiratory rate occurred in 23.3% of patients given IV formulations and in 10.8% of patients given IM formulations.</p><p></p><p>Apnea occurred in 15.4% of patients given IV formulations.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Oral:</p><p><b>Very common</b> (10% or more): Emesis/vomiting (up to 11%)</p><p><b>Common</b> (1% to 10%): Nausea</p><p><b>Frequency not reported</b>: Gagging, salivation</p><p></p><p>Parenteral:</p><p><b>Common</b> (1% to 10%): Nausea, vomiting</p><p><b>Very rare</b> (less than 0.01%): Constipation, dry mouth</p><p><b>Postmarketing reports</b>: Acid taste, excessive salivation, retching, toothache<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Oral:</p><p><b>Common</b> (1% to 10%): Sedation/prolonged sedation, somnolence, depressed levels of consciousness</p><p><b>Frequency not reported</b>: Drooling, dizziness, ataxia, vertigo, dysarthria, loss of balance</p><p></p><p>Parenteral:</p><p><b>Common</b> (1% to 10%): Headache, oversedation, drowsiness, seizure-like activity</p><p><b>Very rare</b> (less than 0.01%): Movement disorder, ataxia, dizziness, seizure, anterograde amnesia</p><p><b>Frequency not reported</b>: Involuntary movements, hyperactivity, decreased alertness, somnolence, prolonged/postoperative sedation, convulsions/drug withdrawal convulsions, feeling faint, tonic/clonic movements and muscle tremor</p><p><b>Postmarketing reports</b>: Vasovagal episode, retrograde amnesia, grogginess, athetoid movements, lethargy, slurred speech, paresthesia, loss of balance, lightheadedness, feeling of burning, emergence delirium or agitation<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>Oral:</p><p><b>Common</b> (1% to 10%): Bradycardia, bigeminy</p><p><b>Frequency not reported</b>: Increased heart rate, cardiac arrest, heart failure, decreased systolic and diastolic blood pressure</p><p></p><p>Parenteral:</p><p><b>Common</b> (1% to 10%): Hypotension</p><p><b>Very rare</b> (less than 0.01%): Bradycardia, cardiac arrest, vasodilation</p><p><b>Frequency not reported</b>: Thrombophlebitis, thrombosis, variations in blood pressure and pulse rate</p><p><b>Postmarketing reports</b>: Bigeminy, premature ventricular contractions, tachycardia, nodal rhythm, hematoma, cardiovascular collapse, cardiovascular reactions, severe cardiorespiratory adverse events<sup>[Ref]</sup></p><h3>Local</h3><p>Parenteral:</p><p><b>Common</b> (1% to 10%): IM injection site pain, IV site tenderness/pain during injection/redness/induration</p><p><b>Uncommon</b> (0.1% to 1%): IM injection site induration/redness/muscle stiffness, IV site phlebitis</p><p><b>Frequency not reported</b>: Injection site erythema, injection site pain</p><p><b>Postmarketing reports</b>: Hive-like elevation at injection site, warmth or coldness at injection site<sup>[Ref]</sup></p><h3>Psychiatric</h3><p>Oral:</p><p><b>Common</b> (1% to 10%): Agitation</p><p><b>Frequency not reported</b>: Dysphoria, disinhibition, excitation, aggression, mood swings, hallucinations, confusion, inappropriate/adverse behavior, behavioral/emotional disorders, euphonia, libido disorders, restlessness, irritability, delusions, anger eruptions, nightmares, psychosis, physical dependency, withdrawal symptoms, abuse, depression (existing, unobserved depression) </p><p></p><p>Parenteral:</p><p><b>Very rare</b> (less than 0.01%): Aggression/aggressiveness, agitation, anger, hallucination, hostility, confusion/confusional state, euphoric mood/euphoria</p><p><b>Frequency not reported</b>: Rage, excitement/paroxysmal excitement, abuse, physical drug dependence and withdrawal syndrome</p><p><b>Postmarketing reports</b>: Argumentativeness, nervousness, anxiety, restlessness, sleep disturbance, insomnia, nightmares, dysphoria, irritability, tension, mood changes, dreaming during sleep<sup>[Ref]</sup></p><h3>Dermatologic</h3><p>Oral:</p><p><b>Common</b> (1% to 10%): Rash</p><p><b>Uncommon</b> (0.1% to 1%): Pruritus and urticaria</p><p></p><p>Parenteral:</p><p><b>Frequency not reported</b>: Angioedema</p><p><b>Postmarketing reports</b>: Hives, rash, pruritus, skin reactions<sup>[Ref]</sup></p><h3>Ocular</h3><p>Oral:</p><p><b>Frequency not reported</b>: Diplopia, strabismus, blurred vision</p><p></p><p>Parenteral:</p><p><b>Common</b> (1% to 10%): Nystagmus</p><p><b>Postmarketing reports</b>: Blurred vision, diplopia, pinpoint pupils, visual disturbance, difficulty focusing eyes, cyclic movement of the eyelids<sup>[Ref]</sup></p><h3>Other</h3><p>Oral:</p><p><b>Frequency not reported</b>: Fatigue, falls</p><p></p><p>Parenteral:</p><p><b>Common</b> (1% to 10%): Paradoxical reaction</p><p><b>Very rare</b> (less than 0.01%): Fatigue, falls, assault/physical assault</p><p><b>Postmarketing reports</b>: Prolonged emergence from anesthesia, blocked ears, chills, weakness, swelling, dreaming during emergence<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>Oral:</p><p><b>Frequency not reported</b>: Hypersensitivity</p><p></p><p>Parenteral:</p><p><b>Frequency not reported</b>: Hypersensitivity, anaphylactic shock</p><p><b>Postmarketing reports</b>: Allergic reaction, anaphylactoid reactions<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>Oral:</p><p><b>Frequency not reported</b>: Muscle weakness, fractures</p><p></p><p>Parenteral:</p><p><b>Frequency not reported</b>: Fractures<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. "Product Information. Versed (midazolam)." Roche Laboratories, Nutley, NJ. </p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><h2>More about Versed (midazolam)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>54 Reviews</li>
<li>Drug class: benzodiazepines</li>
<li>FDA Alerts (5)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Versed injection</li>
<li>Versed &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
<li>Versed Injection &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>ICU Agitation</li>
<li>Light Sedation</li>
<li>Light Anesthesia</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>